Form 8-K - Current report:
SEC Accession No. 0001104659-25-025878
Filing Date
2025-03-20
Accepted
2025-03-20 08:08:12
Documents
14
Period of Report
2025-03-20
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm259617d1_8k.htm   iXBRL 8-K 35293
2 EXHIBIT 99.1 tm259617d1_ex99-1.htm EX-99.1 12825
  Complete submission text file 0001104659-25-025878.txt   231583

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA elev-20250320.xsd EX-101.SCH 3042
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE elev-20250320_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE elev-20250320_pre.xml EX-101.PRE 22377
16 EXTRACTED XBRL INSTANCE DOCUMENT tm259617d1_8k_htm.xml XML 3803
Mailing Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110
Business Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110 7163711125
Elevation Oncology, Inc. (Filer) CIK: 0001783032 (see all company filings)

EIN.: 841771427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40523 | Film No.: 25754565
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)